Citations (169)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Mariana Brütt Pacheco, Vânia Camilo, Rui Henrique & Carmen Jerónimo. (2022) Epigenetic Editing in Prostate Cancer: Challenges and Opportunities. Epigenetics 17:5, pages 564-588.
Read now
Read now
Gurbachan S. Miglani, Anroop Kaur & Lovepreet Kaur. (2020) Plant gene expression control using genome- and epigenome-editing technologies. Journal of Crop Improvement 34:1, pages 1-63.
Read now
Read now
Tobias Anton & Sebastian Bultmann. (2017) Site-specific recruitment of epigenetic factors with a modular CRISPR/Cas system. Nucleus 8:3, pages 279-286.
Read now
Read now
Jarrett D. Morrow, Michael H. Cho, Craig P. Hersh, Victor Pinto-Plata, Bartolome Celli, Nathaniel Marchetti, Gerard Criner, Raphael Bueno, George Washko, Kimberly Glass, Augustine M. K. Choi, John Quackenbush, Edwin K. Silverman & Dawn L. DeMeo. (2016) DNA methylation profiling in human lung tissue identifies genes associated with COPD. Epigenetics 11:10, pages 730-739.
Read now
Read now
Monique G P van der Wijst, Muralidhar Venkiteswaran, Hui Chen, Guo-Liang Xu, Torsten Plösch & Marianne G Rots. (2015) Local chromatin microenvironment determines DNMT activity: from DNA methyltransferase to DNA demethylase or DNA dehydroxymethylase. Epigenetics 10:8, pages 671-676.
Read now
Read now
Christian Huisman, Monique GP van der Wijst, Fahimeh Falahi, Juul Overkamp, Gellért Karsten, Martijn M Terpstra, Klaas Kok, Ate GJ van der Zee, Ed Schuuring, G Bea A Wisman & Marianne G Rots. (2015) Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. Epigenetics 10:5, pages 384-396.
Read now
Read now
Jeremy J. Day. (2014) New approaches to manipulating the epigenome. Dialogues in Clinical Neuroscience 16:3, pages 345-357.
Read now
Read now
David J Gregory, Yiming Zhang, Lester Kobzik & Alexey V Fedulov. (2013) Specific transcriptional enhancement of inducible nitric oxide synthase by targeted promoter demethylation. Epigenetics 8:11, pages 1205-1212.
Read now
Read now
Beatriz Suárez-Álvarez, Aroa Baragaño Raneros, Francisco Ortega & Carlos López-Larrea. (2013) Epigenetic modulation of the immune function. Epigenetics 8:7, pages 694-702.
Read now
Read now
Karla Juárez-Moreno, Rafaela Erices, Adriana S. Beltran, Sabine Stolzenburg, Mauricio Cuello-Fredes, Gareth I. Owen, Haili Qian & Pilar Blancafort. (2013) Breaking through an epigenetic wall. Epigenetics 8:2, pages 164-176.
Read now
Read now
Articles from other publishers (159)
Charlene Waryah, Joseph Cursons, Momeneh Foroutan, Christian Pflueger, Edina Wang, Ramyar Molania, Eleanor Woodward, Anabel Sorolla, Christopher Wallis, Colette Moses, Irina Glas, Leandro Magalhães, Erik W. Thompson, Liam G. Fearnley, Christine L. Chaffer, Melissa Davis, Anthony T. Papenfuss, Andrew Redfern, Ryan Lister, Manel Esteller & Pilar Blancafort. (2023) Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer. Advanced Science 10:22.
Crossref
Crossref
Rebeca Kelly, Diego Aviles, Catriona Krisulevicz, Krystal Hunter, Lauren Krill, David Warshal & Olga Ostrovsky. (2023) The Effects of Natural Epigenetic Therapies in 3D Ovarian Cancer and Patient-Derived Tumor Explants: New Avenues in Regulating the Cancer Secretome. Biomolecules 13:7, pages 1066.
Crossref
Crossref
Jiaying Zhang, Zhuo Wang, Hongzhou Zhao, Yuxuan Wei, Yijian Zhou, Shihui Zhang, Jing Zhao, Xinxin Li, Yong Lin & Kuancan Liu. (2023) The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy. Biomedicine & Pharmacotherapy 163, pages 114764.
Crossref
Crossref
Kartik L. RallapalliAlexis C. Komor. (2023) The Design and Application of DNA-Editing Enzymes as Base Editors. Annual Review of Biochemistry 92:1, pages 43-79.
Crossref
Crossref
Ximei Luo, Yansu Wang, Quan Zou & Lei Xu. (2023) Recall DNA methylation levels at low coverage sites using a CNN model in WGBS. PLOS Computational Biology 19:6, pages e1011205.
Crossref
Crossref
Toshitsugu Fujita & Hodaka Fujii. 2023. Handbook of Epigenetics. Handbook of Epigenetics
843
868
.
Nikoletta Psatha, Kiriaki Paschoudi, Anastasia Papadopoulou & Evangelia Yannaki. (2022) In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations. Genes 13:12, pages 2222.
Crossref
Crossref
Maria P. Morgan, Ellen Finnegan & Sudipto Das. (2022) The role of transcription factors in the acquisition of the four latest proposed hallmarks of cancer and corresponding enabling characteristics. Seminars in Cancer Biology 86, pages 1203-1215.
Crossref
Crossref
Behrouz Shademan, Sepideh Masjedi, Vahidreza Karamad, Alireza Isazadeh, Fatma Sogutlu, Mohammad hosein saeedi rad & Alireza Nourazarian. (2022) CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges. Biochemical Genetics 60:5, pages 1446-1470.
Crossref
Crossref
Bambarendage P. U. Perera, Rachel K. Morgan, Katelyn M. Polemi, Kimmie E. Sala-Hamrick, Laurie K. Svoboda & Dana C. Dolinoy. (2022) PIWI-Interacting RNA (piRNA) and Epigenetic Editing in Environmental Health Sciences. Current Environmental Health Reports 9:4, pages 650-660.
Crossref
Crossref
Alex de Mendoza, Trung Viet Nguyen, Ethan Ford, Daniel Poppe, Sam Buckberry, Jahnvi Pflueger, Matthew R. Grimmer, Sabine Stolzenburg, Ozren Bogdanovic, Alicia Oshlack, Peggy J. Farnham, Pilar Blancafort & Ryan Lister. (2022) Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stability. Genome Biology 23:1.
Crossref
Crossref
J. A. Tuazon, B. Kilburg-Basnyat, L. M. Oldfield, R. Wiscovitch-Russo, K. Dunigan-Russell, A. V. Fedulov, K. J. Oestreich & K. M. Gowdy. (2022) Emerging Insights into the Impact of Air Pollution on Immune-Mediated Asthma Pathogenesis. Current Allergy and Asthma Reports 22:7, pages 77-92.
Crossref
Crossref
Dongbo Lu, Caroline A. Foley, Shama V. Birla, Austin J. Hepperla, Jeremy M. Simon, Lindsey I. James & Nathaniel A. Hathaway. (2022) Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells. ACS Synthetic Biology 11:4, pages 1397-1407.
Crossref
Crossref
Ankita Dey, Moumita Kundu, Subhayan Das, Bikash Chandra Jena & Mahitosh Mandal. (2022) Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:2, pages 188692.
Crossref
Crossref
Marta Marqués, Maria Alba Sorolla, Izaskun Urdanibia, Eva Parisi, Iván Hidalgo, Serafín Morales, Antonieta Salud & Anabel Sorolla. (2022) Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?. Cancers 14:5, pages 1101.
Crossref
Crossref
Ziheng Zhang, Ping Wang & Ji-Long Liu. 2022. CRISPR. CRISPR
93
140
.
Fabian M. Cortés-Mancera, Federica Sarno, Désirée Goubert & Marianne G. Rots. 2022. DNA Methyltransferases - Role and Function. DNA Methyltransferases - Role and Function
515
533
.
Dušan Braný, Dana Dvorská, Ján Strnádel, Tatiana Matáková, Erika Halašová & Henrieta Škovierová. (2021) Effect of Cold Atmospheric Plasma on Epigenetic Changes, DNA Damage, and Possibilities for Its Use in Synergistic Cancer Therapy. International Journal of Molecular Sciences 22:22, pages 12252.
Crossref
Crossref
Russell A. Li & Zhandong Liu. (2021) A hybrid deep neural network for robust single-cell genome-wide DNA methylation detection. A hybrid deep neural network for robust single-cell genome-wide DNA methylation detection.
Krystyna Ślaska-Kiss, Nikolett Zsibrita, Mihály Koncz, Pál Albert, Ákos Csábrádi, Sarolta Szentes & Antal Kiss. (2021) Lowering DNA binding affinity of SssI DNA methyltransferase does not enhance the specificity of targeted DNA methylation in E. coli. Scientific Reports 11:1.
Crossref
Crossref
Rezvan Noroozi, Soudeh Ghafouri-Fard, Aleksandra Pisarek, Joanna Rudnicka, Magdalena Spólnicka, Wojciech Branicki, Mohammad Taheri & Ewelina Pośpiech. (2021) DNA methylation-based age clocks: From age prediction to age reversion. Ageing Research Reviews 68, pages 101314.
Crossref
Crossref
Sarah Balderston, Gabrielle ClouseJuan-José RipollGrace K. PrattGiedrius GasiunasJens-Ole BockEric Paul BennettKiana Aran. (2021) Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing. The CRISPR Journal 4:3, pages 400-415.
Crossref
Crossref
Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri & Pilar Blancafort. (2021) Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing. Molecular Therapy - Methods & Clinical Development 21, pages 592-606.
Crossref
Crossref
Tristan A. Scott, Denis O’Meally, Nicole Anne Grepo, Citradewi Soemardy, Daniel C. Lazar, Yue Zheng, Marc S. Weinberg, Vicente Planelles & Kevin V. Morris. (2021) Broadly active zinc finger protein-guided transcriptional activation of HIV-1. Molecular Therapy - Methods & Clinical Development 20, pages 18-29.
Crossref
Crossref
Kateryna Fal, Denisa Tomkova, Gilles Vachon, Marie-Edith Chabouté, Alexandre Berr & Cristel C. Carles. (2021) Chromatin Manipulation and Editing: Challenges, New Technologies and Their Use in Plants. International Journal of Molecular Sciences 22:2, pages 512.
Crossref
Crossref
Agustin Sgro & Pilar Blancafort. (2020) Epigenome engineering: new technologies for precision medicine. Nucleic Acids Research 48:22, pages 12453-12482.
Crossref
Crossref
Clémence Topart, Emilie Werner & Paola B. Arimondo. (2020) Wandering along the epigenetic timeline. Clinical Epigenetics 12:1.
Crossref
Crossref
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, Annika Nelde, Juliane S. Walz, Stefan Winter, Siahei Kandabarau, Florian Büttner, Mathias Haag, Linus Backert, Daniel J. Kowalewski, Steffen Rausch, Jörg Hennenlotter, Viktoria Stühler, Marcus Scharpf, Falko Fend, Arnulf Stenzl, Hans-Georg Rammensee, Jens Bedke, Stefan Stevanović, Matthias Schwab & Elke Schaeffeler. (2020) Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Genome Medicine 12:1.
Crossref
Crossref
Ponne Saravanaraman, Murugan Selvam, Cheemala Ashok, Loudu Srijyothi & Sudhakar Baluchamy. (2020) De novo methyltransferases: Potential players in diseases and new directions for targeted therapy. Biochimie 176, pages 85-102.
Crossref
Crossref
Chang K. Sung & Hyungshin Yim. (2020) CRISPR-mediated promoter de/methylation technologies for gene regulation. Archives of Pharmacal Research 43:7, pages 705-713.
Crossref
Crossref
Xiaofeng Dai, Pilar Blancafort, Peiyu Wang, Agustin Sgro, Erik W. Thompson & Kostya (Ken) Ostrikov. (2020) Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine. Advanced Science 7:12, pages 1902552.
Crossref
Crossref
Rutger A. F. Gjaltema, Désirée Goubert, Christian Huisman, Consuelo del Pilar García Tobilla, Mihály Koncz, Pytrick G. Jellema, Dandan Wu, Uilke Brouwer, Antal Kiss, Pernette J. Verschure, Ruud A. Bank & Marianne G. Rots. (2020) KRAB-Induced Heterochromatin Effectively Silences PLOD2 Gene Expression in Somatic Cells and Is Resilient to TGFβ1 Activation. International Journal of Molecular Sciences 21:10, pages 3634.
Crossref
Crossref
Ke Wang, Qiang Gong & Xingguo Ye. (2019) Recent developments and applications of genetic transformation and genome editing technologies in wheat. Theoretical and Applied Genetics 133:5, pages 1603-1622.
Crossref
Crossref
Linn Amanda Syding, Petr Nickl, Petr Kasparek & Radislav Sedlacek. (2020) CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review. Cells 9:4, pages 993.
Crossref
Crossref
Anna M. Chiarella, Dongbo Lu & Nathaniel A. Hathaway. (2020) Epigenetic Control of a Local Chromatin Landscape. International Journal of Molecular Sciences 21:3, pages 943.
Crossref
Crossref
Taiga Yamazaki, Yu Hatano, Ryoya Taniguchi, Noritada Kobayashi & Kazuo Yamagata. (2020) Editing DNA Methylation in Mammalian Embryos. International Journal of Molecular Sciences 21:2, pages 637.
Crossref
Crossref
Daniel Hofacker, Julian Broche, Laura Laistner, Sabrina Adam, Pavel Bashtrykov & Albert Jeltsch. (2020) Engineering of Effector Domains for Targeted DNA Methylation with Reduced Off-Target Effects. International Journal of Molecular Sciences 21:2, pages 502.
Crossref
Crossref
Christian Pflueger, Tessa Swain & Ryan Lister. (2019) Harnessing targeted DNA methylation and demethylation using dCas9. Essays in Biochemistry 63:6, pages 813-825.
Crossref
Crossref
Lanqi Gong, Qian Yan, Yu Zhang, Xiaona Fang, Beilei Liu & Xinyuan Guan. (2019) Cancer cell reprogramming: a promising therapy converting malignancy to benignity. Cancer Communications 39:1, pages 48.
Crossref
Crossref
Martina Baumann, Gerald Klanert, Sabine Vcelar, Marcus Weinguny, Nicolas Marx & Nicole Borth. 2019. Cell Culture Engineering. Cell Culture Engineering
97
126
.
Mohammad Mijanur Rahman, Andrew C. Brane & Trygve O. Tollefsbol. (2019) MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer. Cells 8:10, pages 1214.
Crossref
Crossref
Ordoñez, Martínez-Calle, Agirre & Prosper. (2019) DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?. Cancers 11:10, pages 1424.
Crossref
Crossref
Alia Abukiwan & Martin R. Berger. 2019. DNA Repair- An Update. DNA Repair- An Update.
José Francisco Herrera-Moreno, Irma Martha Medina-Díaz, Yael Yvette Bernal-Hernández, Kenneth S. Ramos, Isabel Alvarado-Cruz, Betzabet Quintanilla-Vega, Cyndia Azucena González-Arias, Briscia Socorro Barrón-Vivanco & Aurora Elizabeth Rojas-García. (2019) Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators. Environmental Science and Pollution Research 26:15, pages 15124-15135.
Crossref
Crossref
Xutao Chen, Mengying Wei, Xiangwei Liu, Shuang Song, Lei Wang, Xuekang Yang & Yingliang Song. (2019) Construction and validation of the CRISPR/dCas9-EZH2 system for targeted H3K27Me3 modification. Biochemical and Biophysical Research Communications 511:2, pages 246-252.
Crossref
Crossref
Danielle R. Lenz, Niliksha Gunewardene, Dunia E. Abdul-Aziz, Quan Wang, Tyler M. Gibson & Albert S. B. Edge. (2019) Applications of Lgr5-Positive Cochlear Progenitors (LCPs) to the Study of Hair Cell Differentiation. Frontiers in Cell and Developmental Biology 7.
Crossref
Crossref
Benoît Aliaga, Ingo Bulla, Gabriel Mouahid, David Duval & Christoph Grunau. (2019) Universality of the DNA methylation codes in Eucaryotes. Scientific Reports 9:1.
Crossref
Crossref
David T Ewart, Erik J Peterson & Clifford J Steer. (2019) Gene editing for inflammatory disorders. Annals of the Rheumatic Diseases 78:1, pages 6-15.
Crossref
Crossref
Amanda J Lea, Christopher M Vockley, Rachel A Johnston, Christina A Del Carpio, Luis B Barreiro, Timothy E Reddy & Jenny Tung. (2018) Genome-wide quantification of the effects of DNA methylation on human gene regulation. eLife 7.
Crossref
Crossref
Yong Lei, Yung-Hsin Huang & Margaret A. Goodell. (2018) DNA methylation and de-methylation using hybrid site-targeting proteins. Genome Biology 19:1.
Crossref
Crossref
Cia-Hin Lau & Yousin Suh. (2018) In vivo epigenome editing and transcriptional modulation using CRISPR technology. Transgenic Research 27:6, pages 489-509.
Crossref
Crossref
Matlock A. Jeffries. (2018) Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy. Clinical Immunology 196, pages 49-58.
Crossref
Crossref
Christian Pflueger, Dennis Tan, Tessa Swain, Trung Nguyen, Jahnvi Pflueger, Christian Nefzger, Jose M. Polo, Ethan Ford & Ryan Lister. (2018) A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs. Genome Research 28:8, pages 1193-1206.
Crossref
Crossref
T. M. Geel, M. H. J. Ruiters, R. H. Cool, L. Halby, D. C. Voshart, L. Andrade Ruiz, K. E. Niezen-Koning, P. B. Arimondo & M. G. Rots. (2018) The past and presence of gene targeting: from chemicals and DNA via proteins to RNA. Philosophical Transactions of the Royal Society B: Biological Sciences 373:1748, pages 20170077.
Crossref
Crossref
Hong Wang, Rui Guo, Zhonghua Du, Ling Bai, Lingyu Li, Jiuwei Cui, Wei Li, Andrew R. Hoffman & Ji-Fan Hu. (2018) Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors. Molecular Therapy - Nucleic Acids 11, pages 23-33.
Crossref
Crossref
Tafadzwa Mlambo, Sandra Nitsch, Markus Hildenbeutel, Marianna Romito, Maximilian Müller, Claudia Bossen, Sven Diederichs, Tatjana I Cornu, Toni Cathomen & Claudio Mussolino. (2018) Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells. Nucleic Acids Research 46:9, pages 4456-4468.
Crossref
Crossref
Colette Moses, Benjamin Garcia-Bloj, Alan R. Harvey & Pilar Blancafort. (2018) Hallmarks of cancer: The CRISPR generation. European Journal of Cancer 93, pages 10-18.
Crossref
Crossref
Lin Lin, Yong Liu, Fengping Xu, Jinrong Huang, Tina Fuglsang Daugaard, Trine Skov Petersen, Bettina Hansen, Lingfei Ye, Qing Zhou, Fang Fang, Ling Yang, Shengting Li, Lasse Fløe, Kristopher Torp Jensen, Ellen Shrock, Fang Chen, Huanming Yang, Jian Wang, Xin Liu, Xun Xu, Lars Bolund, Anders Lade Nielsen & Yonglun Luo. (2018) Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases. GigaScience 7:3.
Crossref
Crossref
Shota Nakade, Takashi Yamamoto & Tetsushi Sakuma. (2017) Cancer induction and suppression with transcriptional control and epigenome editing technologies. Journal of Human Genetics 63:2, pages 187-194.
Crossref
Crossref
Dan-Dan Wu, Juan Song, Sabine Bartel, Susanne Krauss-Etschmann, Marianne G. Rots & Machteld N. Hylkema. (2018) The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach. Pharmacology & Therapeutics 182, pages 1-14.
Crossref
Crossref
Ke Wang, Bisma Riaz & Xingguo Ye. (2018) Wheat genome editing expedited by efficient transformation techniques: Progress and perspectives. The Crop Journal 6:1, pages 22-31.
Crossref
Crossref
Pavel Bashtrykov & Albert Jeltsch. 2018. Epigenome Editing. Epigenome Editing
137
146
.
Peter J. Hamilton, Carissa J. Lim, Eric J. Nestler & Elizabeth A. Heller. 2018. Epigenome Editing. Epigenome Editing
113
136
.
Dilara Sen & Albert J. Keung. 2018. Epigenome Editing. Epigenome Editing
65
87
.
Désirée Goubert, Mihály Koncz, Antal Kiss & Marianne G. Rots. 2018. Epigenome Editing. Epigenome Editing
395
415
.
Charlene Babra Waryah, Colette Moses, Mahira Arooj & Pilar Blancafort. 2018. Epigenome Editing. Epigenome Editing
19
63
.
Carolin Kroll & Philipp Rathert. 2018. Epigenome Editing. Epigenome Editing
215
225
.
Jennifer Imm, Talitha L Kerrigan, Aaron Jeffries & Katie Lunnon. (2017) Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease. Epigenomics 9:11, pages 1455-1468.
Crossref
Crossref
Josep Mari-Alexandre, Angel Diaz-Lagares, Maria Villalba, Oscar Juan, Ana B. Crujeiras, Alfonso Calvo & Juan Sandoval. (2017) Translating cancer epigenomics into the clinic: focus on lung cancer. Translational Research 189, pages 76-92.
Crossref
Crossref
Henriette O’Geen, Chonghua Ren, Charles M. Nicolet, Andrew A. Perez, Julian Halmai, Victoria M. Le, Joel P. Mackay, Peggy J. Farnham & David J. Segal. (2017) dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression. Nucleic Acids Research 45:17, pages 9901-9916.
Crossref
Crossref
Tina Xiong, Glenna E. Meister, Rachael E. Workman, Nathaniel C. Kato, Michael J. Spellberg, Fulya Turker, Winston Timp, Marc Ostermeier & Carl D. Novina. (2017) Targeted DNA methylation in human cells using engineered dCas9-methyltransferases. Scientific Reports 7:1.
Crossref
Crossref
Joshua B. Black, Pablo Perez-Pinera & Charles A. Gersbach. (2017) Mammalian Synthetic Biology: Engineering Biological Systems. Annual Review of Biomedical Engineering 19:1, pages 249-277.
Crossref
Crossref
Kai O. Hensel, Julio C. Rendon, Maria-Cristina Navas, Marianne G. Rots & Jan Postberg. (2017) Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies. The FEBS Journal.
Crossref
Crossref
Taiga Yamazaki, Yu Hatano, Tetsuya Handa, Sakiko Kato, Kensuke Hoida, Rui Yamamura, Takashi Fukuyama, Takayuki Uematsu, Noritada Kobayashi, Hiroshi Kimura & Kazuo Yamagata. (2017) Targeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase. PLOS ONE 12:5, pages e0177764.
Crossref
Crossref
Jerzy Kawiak, Grazyna Hoser & Joanna Domagała-Kulawik. (2017) Problems of Cancer Treatment. Part I. Theory of Treatment Based on Known Mechanisms of Anticancer Immunological Responses. Advances in Cell Biology 5:1, pages 72-95.
Crossref
Crossref
Juan Song, David Cano-RodriquezMelanie WinkleRutger A. F. GjaltemaDésirée GoubertTomasz P. Jurkowski, Irene H. HeijinkMarianne G. RotsMachteld N. Hylkema. (2017) Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 312:3, pages L334-L347.
Crossref
Crossref
Junxiao Deng, Xiying Qu, Panpan Lu, Xinyi Yang, Yuqi Zhu, Haiyan Ji, Yanan Wang, Zhengtao Jiang, Xian Li, Yangcheng Zhong, He Yang, Hanyu Pan, Won-Bin Young & Huanzhang Zhu. (2017) Specific and Stable Suppression of HIV Provirus Expression In Vitro by Chimeric Zinc Finger DNA Methyltransferase 1. Molecular Therapy - Nucleic Acids 6, pages 233-242.
Crossref
Crossref
D Goubert, W F Beckman, P J Verschure & M G Rots. (2017) Epigenetic editing: towards realization of the curable genome concept. Convergent Science Physical Oncology 3:1, pages 013006.
Crossref
Crossref
Elisabeth J. Radford, Anne C. Ferguson-Smith & Sacri R. Ferrón. 2017. Handbook of Neurobehavioral Genetics and Phenotyping. Handbook of Neurobehavioral Genetics and Phenotyping
357
393
.
Daniela Cornacchia & Lorenz Studer. (2017) Back and forth in time: Directing age in iPSC-derived lineages. Brain Research 1656, pages 14-26.
Crossref
Crossref
Glen P. Liszczak, Zachary Z. Brown, Samuel H. Kim, Rob C. Oslund, Yael David & Tom W. Muir. (2017) Genomic targeting of epigenetic probes using a chemically tailored Cas9 system. Proceedings of the National Academy of Sciences 114:4, pages 681-686.
Crossref
Crossref
Suet-Hui Ow, Pei-Jou Chua & Boon-Huat Bay. (2016) Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer. Experimental Biology and Medicine 242:2, pages 140-147.
Crossref
Crossref
Stefan H. Stricker, Anna Köferle & Stephan Beck. (2016) From profiles to function in epigenomics. Nature Reviews Genetics 18:1, pages 51-66.
Crossref
Crossref
S. Majumdar, P. Singh, A.H. Iyer & M. Saravanan. 2017. Current Developments in Biotechnology and Bioengineering. Current Developments in Biotechnology and Bioengineering
3
26
.
Yoichi Gondo, Shigeru Makino & Ryutaro Fukumura. 2017. Animal Models for the Study of Human Disease. Animal Models for the Study of Human Disease
727
752
.
Toshitsugu Fujita & Hodaka Fujii. 2017. Handbook of Epigenetics. Handbook of Epigenetics
635
652
.
Venu (Kal) Kalavacharla, Mayavan Subramani, Vasudevan Ayyappan, Mollee C. Dworkin & Rita K. Hayford. 2017. Handbook of Epigenetics. Handbook of Epigenetics
245
258
.
Christoph Grunau. 2017. Ecology and Evolution of Cancer. Ecology and Evolution of Cancer
87
98
.
A.D. Dekker, P.P. De Deyn & M.G. Rots. 2017. Neuropsychiatric Disorders and Epigenetics. Neuropsychiatric Disorders and Epigenetics
163
184
.
Barbara Bailus, Ningzhe Zhang & Lisa M. Ellerby. 2017. Genome Editing in Neurosciences. Genome Editing in Neurosciences
87
101
.
Pavel Bashtrykov & Albert Jeltsch. 2017. Neuroepigenomics in Aging and Disease. Neuroepigenomics in Aging and Disease
409
424
.
Julio Cesar Rendón, David Cano-Rodríguez & Marianne G. Rots. 2017. Functional Genomics. Functional Genomics
321
335
.
Minhee Park, Albert J. Keung & Ahmad S. Khalil. (2016) The epigenome: the next substrate for engineering. Genome Biology 17:1.
Crossref
Crossref
Thomas Gaj, Shannon J. Sirk, Sai-lan Shui & Jia Liu. (2016) Genome-Editing Technologies: Principles and Applications. Cold Spring Harbor Perspectives in Biology 8:12, pages a023754.
Crossref
Crossref
David Cano-Rodriguez & Marianne G. Rots. (2016) Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will. Current Genetic Medicine Reports 4:4, pages 170-179.
Crossref
Crossref
Ali Noman, Muhammad Aqeel & Shuilin He. (2016) CRISPR-Cas9: Tool for Qualitative and Quantitative Plant Genome Editing. Frontiers in Plant Science 7.
Crossref
Crossref
Benjamin Garcia-Bloj, Colette Moses, Agustin Sgro, Janice Plani-Lam, Mahira Arooj, Ciara Duffy, Shreyas Thiruvengadam, Anabel Sorolla, Rabab Rashwan, Ricardo L. Mancera, Andrea Leisewitz, Theresa Swift-Scanlan, Alejandro H. Corvalan & Pilar Blancafort. (2016) Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system. Oncotarget 7:37, pages 60535-60554.
Crossref
Crossref
Suhani Vora, Marcelle Tuttle, Jenny Cheng & George Church. (2016) Next stop for the CRISPR revolution: RNA‐guided epigenetic regulators. The FEBS Journal 283:17, pages 3181-3193.
Crossref
Crossref
David Cano-Rodriguez, Rutger A F. Gjaltema, Laura J Jilderda, Pytrick Jellema, Jelleke Dokter-Fokkens, Marcel H J. Ruiters & Marianne G Rots. (2016) Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner. Nature Communications 7:1.
Crossref
Crossref
Aleksandar Vojta, Paula Dobrinić, Vanja Tadić, Luka Bočkor, Petra Korać, Boris Julg, Marija Klasić & Vlatka Zoldoš. (2016) Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Research 44:12, pages 5615-5628.
Crossref
Crossref
Holger Puchta. (2016) Using CRISPR/Cas in three dimensions: towards synthetic plant genomes, transcriptomes and epigenomes. The Plant Journal 87:1, pages 5-15.
Crossref
Crossref
Haifeng WangMarie La Russa & Lei S. Qi. (2016) CRISPR/Cas9 in Genome Editing and Beyond. Annual Review of Biochemistry 85:1, pages 227-264.
Crossref
Crossref
Grzegorz Kubik & Daniel Summerer. (2016) TALEored Epigenetics: A DNA-Binding Scaffold for Programmable Epigenome Editing and Analysis. ChemBioChem 17:11, pages 975-980.
Crossref
Crossref
Miho Ishida. (2016) New developments in Silver–Russell syndrome and implications for clinical practice. Epigenomics 8:4, pages 563-580.
Crossref
Crossref
Yiheng Wang, Tong Liu, Dong Xu, Huidong Shi, Chaoyang Zhang, Yin-Yuan Mo & Zheng Wang. (2016) Predicting DNA Methylation State of CpG Dinucleotide Using Genome Topological Features and Deep Networks. Scientific Reports 6:1.
Crossref
Crossref
Pratiksha I Thakore, Joshua B Black, Isaac B Hilton & Charles A Gersbach. (2016) Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nature Methods 13:2, pages 127-137.
Crossref
Crossref
Goran Kungulovski & Albert Jeltsch. (2016) Epigenome Editing: State of the Art, Concepts, and Perspectives. Trends in Genetics 32:2, pages 101-113.
Crossref
Crossref
Sabine Stolzenburg, Désirée Goubert & Marianne G. Rots. 2016. DNA Methyltransferases - Role and Function. DNA Methyltransferases - Role and Function
475
490
.
Ailbhe Jane Brazel & Douglas Vernimmen. (2016) The complexity of epigenetic diseases. The Journal of Pathology 238:2, pages 333-344.
Crossref
Crossref
Tomasz P Jurkowski, Mirunalini Ravichandran & Peter Stepper. (2015) Synthetic epigenetics—towards intelligent control of epigenetic states and cell identity. Clinical Epigenetics 7:1.
Crossref
Crossref
Anna Köferle, Stefan H. Stricker & Stephan Beck. (2015) Brave new epigenomes: the dawn of epigenetic engineering. Genome Medicine 7:1.
Crossref
Crossref
Benjamin I. Laufer & Shiva M. Singh. (2015) Strategies for precision modulation of gene expression by epigenome editing: an overview. Epigenetics & Chromatin 8:1.
Crossref
Crossref
Goran Kungulovski, Suneetha Nunna, Maria Thomas, Ulrich M Zanger, Richard Reinhardt & Albert Jeltsch. (2015) Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintained. Epigenetics & Chromatin 8:1.
Crossref
Crossref
Chenghua Cui, Ying Gan, Liankun Gu, James Wilson, Zhaojun Liu, Baozhen Zhang & Dajun Deng. (2015) P16-specific DNA methylation by engineered zinc finger methyltransferase inactivates gene transcription and promotes cancer metastasis. Genome Biology 16:1.
Crossref
Crossref
Weiwei Zhang, Tim D Spector, Panos Deloukas, Jordana T Bell & Barbara E Engelhardt. (2015) Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements. Genome Biology 16:1.
Crossref
Crossref
Pratiksha I Thakore, Anthony M D'Ippolito, Lingyun Song, Alexias Safi, Nishkala K Shivakumar, Ami M Kabadi, Timothy E Reddy, Gregory E Crawford & Charles A Gersbach. (2015) Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nature Methods 12:12, pages 1143-1149.
Crossref
Crossref
Mir A. Hossain, Joeva J. Barrow, Yong Shen, MD Imdadul Haq & Jörg Bungert. (2015) Artificial Zinc Finger DNA Binding Domains: Versatile Tools for Genome Engineering and Modulation of Gene Expression. Journal of Cellular Biochemistry 116:11, pages 2435-2444.
Crossref
Crossref
Isaac B. Hilton & Charles A. Gersbach. (2015) Enabling functional genomics with genome engineering. Genome Research 25:10, pages 1442-1455.
Crossref
Crossref
S Stolzenburg, A S Beltran, T Swift-Scanlan, A G Rivenbark, R Rashwan & P Blancafort. (2015) Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer. Oncogene 34:43, pages 5427-5435.
Crossref
Crossref
HAIPENG ZHU, FENG YUN, XIAOXUE SHI & DONG WANG. (2015) Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin. International Journal of Molecular Medicine 36:2, pages 595-601.
Crossref
Crossref
Shaohua Yao, Zhiyao He & Chong Chen. (2015) CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy. Human Gene Therapy 26:7, pages 463-471.
Crossref
Crossref
Sandrine M. Géranton & Keri K. Tochiki. (2015) Could targeting epigenetic processes relieve chronic pain states?. Current Opinion in Supportive & Palliative Care 9:2, pages 138-146.
Crossref
Crossref
Diana L. Bernstein, John E. Le Lay, Elena G. Ruano & Klaus H. Kaestner. (2015) TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts. Journal of Clinical Investigation 125:5, pages 1998-2006.
Crossref
Crossref
Isaac B Hilton, Anthony M D'Ippolito, Christopher M Vockley, Pratiksha I Thakore, Gregory E Crawford, Timothy E Reddy & Charles A Gersbach. (2015) Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nature Biotechnology 33:5, pages 510-517.
Crossref
Crossref
Ke Li, Jun Pang, Huaiyan Cheng, Wei-Peng Liu, Jin-Ming Di, Heng-Jun Xiao, Yun Luo, Hao Zhang, Wen-Tao Huang, Ming-Kun Chen, Liao-Yuan Li, Chun-Kui Shao, Ying-Hong Feng & Xin Gao. (2015) Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase. Oncotarget 6:12, pages 10030-10044.
Crossref
Crossref
Sandra Meyer & Bruno Kieffer. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
8
.
Albert J. Keung, J. Keith Joung, Ahmad S. Khalil & James J. Collins. (2015) Chromatin regulation at the frontier of synthetic biology. Nature Reviews Genetics 16:3, pages 159-171.
Crossref
Crossref
Fahimeh Falahi, Agustin Sgro & Pilar Blancafort. (2015) Epigenome Engineering in Cancer: Fairytale or a Realistic Path to the Clinic?. Frontiers in Oncology 5.
Crossref
Crossref
Sandrine M. Géranton & Keri K. Tochiki. 2015. Molecular and Cell Biology of Pain. Molecular and Cell Biology of Pain
147
183
.
Aurore Claude-Taupin, Michael Boyer-Guittaut, Régis Delage-Mourroux & Eric Hervouet. 2015. Cancer Epigenetics. Cancer Epigenetics
487
509
.
Monique G.P. van der Wijst, Robert Brown & Marianne G. Rots. (2014) Nrf2, the master redox switch: The Achilles' heel of ovarian cancer?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 494-509.
Crossref
Crossref
Matthew R Grimmer & Peggy J Farnham. (2014) Can genome engineering be used to target cancer-associated enhancers?. Epigenomics 6:5, pages 493-501.
Crossref
Crossref
Stefano de Pretis & Mattia Pelizzola. (2014) Computational and experimental methods to decipher the epigenetic code. Frontiers in Genetics 5.
Crossref
Crossref
Matthew R. Grimmer, Sabine Stolzenburg, Ethan Ford, Ryan Lister, Pilar Blancafort & Peggy J. Farnham. (2014) Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation. Nucleic Acids Research 42:16, pages 10856-10868.
Crossref
Crossref
Alain D. Dekker, Peter P. De Deyn & Marianne G. Rots. (2014) Epigenetics: The neglected key to minimize learning and memory deficits in Down syndrome. Neuroscience & Biobehavioral Reviews 45, pages 72-84.
Crossref
Crossref
Charles A. Gersbach, Thomas Gaj & Carlos F. BarbasIIIIII. (2014) Synthetic Zinc Finger Proteins: The Advent of Targeted Gene Regulation and Genome Modification Technologies. Accounts of Chemical Research 47:8, pages 2309-2318.
Crossref
Crossref
Fahimeh Falahi, Michel van Kruchten, Nadine Martinet, Geke Hospers & Marianne G Rots. (2014) Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer. Breast Cancer Research 16:4.
Crossref
Crossref
Maxim Ivanov, Isabel Barragan & Magnus Ingelman-Sundberg. (2014) Epigenetic mechanisms of importance for drug treatment. Trends in Pharmacological Sciences 35:8, pages 384-396.
Crossref
Crossref
Juan E Castillo-Fernandez, Tim D Spector & Jordana T Bell. (2014) Epigenetics of discordant monozygotic twins: implications for disease. Genome Medicine 6:7.
Crossref
Crossref
Brian Chaikind & Marc Ostermeier. (2014) Directed Evolution of Improved Zinc Finger Methyltransferases. PLoS ONE 9:5, pages e96931.
Crossref
Crossref
Hui Chen, Hinke G Kazemier, Marloes L. de Groote, Marcel H. J. Ruiters, Guo-Liang Xu & Marianne G. Rots. (2014) Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Research 42:3, pages 1563-1574.
Crossref
Crossref
Suneetha Nunna, Richard Reinhardt, Sergey Ragozin & Albert Jeltsch. (2014) Targeted Methylation of the Epithelial Cell Adhesion Molecule (EpCAM) Promoter to Silence Its Expression in Ovarian Cancer Cells. PLoS ONE 9:1, pages e87703.
Crossref
Crossref
Takuro Horii. (2014) Genome engineering using the CRISPR/Cas system. World Journal of Medical Genetics 4:3, pages 69.
Crossref
Crossref
Gabrielle A Lockett, Veeresh K Patil, Nelís Soto-Ramírez, Ali H Ziyab, John W Holloway & Wilfried Karmaus. (2013) Epigenomics and allergic disease. Epigenomics 5:6, pages 685-699.
Crossref
Crossref
Morgan L Maeder, James F Angstman, Marcy E Richardson, Samantha J Linder, Vincent M Cascio, Shengdar Q Tsai, Quan H Ho, Jeffry D Sander, Deepak Reyon, Bradley E Bernstein, Joseph F Costello, Miles F Wilkinson & J Keith Joung. (2013) Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nature Biotechnology 31:12, pages 1137-1142.
Crossref
Crossref
Pascale Fisel, Stephan Kruck, Stefan Winter, Jens Bedke, Jörg Hennenlotter, Anne T. Nies, Marcus Scharpf, Falko Fend, Arnulf Stenzl, Matthias Schwab & Elke Schaeffeler. (2013)
DNA Methylation of the
SLC16A3
Promoter Regulates Expression of the Human Lactate Transporter MCT4 in Renal Cancer with Consequences for Clinical Outcome
. Clinical Cancer Research 19:18, pages 5170-5181.
Crossref
Crossref
Fahimeh Falahi, Christian Huisman, Hinke G. Kazemier, Pieter van der Vlies, Klaas Kok, Geke A.P. Hospers & Marianne G. Rots. (2013) Towards Sustained Silencing of HER2/neu in Cancer By Epigenetic Editing. Molecular Cancer Research 11:9, pages 1029-1039.
Crossref
Crossref
Fei GaoYudong Xia. (2013) Hydroxymethylation- and methylation-sensitive tag sequencing: how will this technology change clinical applications of DNA methylation profiling?. Epigenomics 5:4, pages 355-357.
Crossref
Crossref
Helena Carén, Steven M. Pollard & Stephan Beck. (2013) The good, the bad and the ugly: Epigenetic mechanisms in glioblastoma. Molecular Aspects of Medicine 34:4, pages 849-862.
Crossref
Crossref
Mark J. Millan. (2013) An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy. Neuropharmacology 68, pages 2-82.
Crossref
Crossref
Pilar Blancafort, Jian Jin & Stephen Frye. (2013) Writing and Rewriting the Epigenetic Code of Cancer Cells: From Engineered Proteins to Small Molecules. Molecular Pharmacology 83:3, pages 563-576.
Crossref
Crossref
Abu Nasar Siddique, Suneetha Nunna, Arumugam Rajavelu, Yingying Zhang, Renata Z. Jurkowska, Richard Reinhardt, Marianne G. Rots, Sergey Ragozin, Tomasz P. Jurkowski & Albert Jeltsch. (2013) Targeted Methylation and Gene Silencing of VEGF-A in Human Cells by Using a Designed Dnmt3a–Dnmt3L Single-Chain Fusion Protein with Increased DNA Methylation Activity. Journal of Molecular Biology 425:3, pages 479-491.
Crossref
Crossref
Matthias Lechner, Tim Fenton, James West, Gareth Wilson, Andrew Feber, Stephen Henderson, Christina Thirlwell, Harpreet K Dibra, Amrita Jay, Lee Butcher, Ankur R Chakravarthy, Fiona Gratrix, Nirali Patel, Francis Vaz, Paul O'Flynn, Nicholas Kalavrezos, Andrew E Teschendorff, Chris Boshoff & Stephan Beck. (2013) Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Medicine 5:2, pages 15.
Crossref
Crossref
Randall S. Prather, Monique LorsonJason W. RossJeffrey J. Whyte & Eric Walters. (2013) Genetically Engineered Pig Models for Human Diseases. Annual Review of Animal Biosciences 1:1, pages 203-219.
Crossref
Crossref
Chunhong Yan & Paul J. Higgins. (2013) Drugging the undruggable: Transcription therapy for cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1835:1, pages 76-85.
Crossref
Crossref
Christopher G. Bell. 2013. Epigenetics and Complex Traits. Epigenetics and Complex Traits
287
317
.
M. L. de Groote, P. J. Verschure & M. G. Rots. (2012) Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Research 40:21, pages 10596-10613.
Crossref
Crossref
Sabine Stolzenburg, Marianne G. Rots, Adriana S. Beltran, Ashley G. Rivenbark, Xinni Yuan, Haili Qian, Brian D. Strahl & Pilar Blancafort. (2012) Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Research 40:14, pages 6725-6740.
Crossref
Crossref
Krystyna Ślaska-Kiss, Edit Tímár & Antal Kiss. (2012) Complementation between inactive fragments of SssI DNA methyltransferase. BMC Molecular Biology 13:1, pages 17.
Crossref
Crossref